BioSpace News Archive

Dravet syndrome is a rare , life-long, infant- and childhood- onset epilepsy associated with severe, treatment-resistant seizures CHMP positive opinion based on Phase 3 study data that demonstrat e d FINTEPLA ® significantly reduced convulsive seizure frequency in patients whose seizures were not adequately controlled on other medications, including stiripentol Final d ecision on Marketing Authorization Application expected by year-end 2020

Bristol Myers Squibb Receives Positive CHMP Opinion Recommending Opdivo (nivolumab) as Second-Line Treatment for Unresectable Advanced, Recurrent or Metastatic Esophageal Squamous Cell Carcinoma Application based on Phase 3 ATTRACTION-3 trial demonstrating a statistically significant and clinically meaningful improvement in patients’ overall survival compared to chemotherapy PRINCETON, N.J.--( BUSINESS WIRE )-- Bristol Myers Squibb (NYSE:BMY) to

Almirall, S.A. (ALM ) has launched its second innovation challenge open to worldwide startups who can disrupt the future of digital health. Start-ups can apply between now and October 31 at almiralldigitalgarden.com for a chance to participate in the nine-month accelerator program Digital Garden , powered by Almirall

One-of-a-Kind Therapeutic Device Enables Tandem Treatment of Multiple Areas of Pain; U.S. Patent Pending

- Data continue to support the unique clinical attributes for Neurelis’ lead product, VALTOCO® (diazepam nasal spray), the first and only nasal spray treatment for seizure cluster rescue in pediatric patients 6 years of age and older, adolescents, and adults - Data also highlight that 88 percent of treated seizure episodes used a single dose of VALTOCO

Diabetes is a major healthcare challenge across the world as its incidence grows considerably over the world owing to poor lifestyle choices such as sedentary living, poor and unbalanced diets and excessive stress.

In the domain of patient’s health management, medical nutrition is a focused component. It makes an assessment of the nutrition status of the patients and assists in improving the immune system of the patient.

Telemedicine is the use of telecommunications and information technologies to share information and provide clinical care, education, public health, and administrative services

Avalyn Pharma Inc., a biopharmaceutical company focused on development of improved therapies for life threatening pulmonary diseases, announced completion of last patient in the initial 24 week evaluation of a Phase I/II clinical study of two dose regimens of AP01 in patients with idiopathic pulmonary fibrosis.

Nanotechnology company BNNano, Inc., biotechnology company Calviri, Inc., and electronics materials company Terecircuits Corporation claimed top recognition on Pepperdine Graziadio Business School’s third annual Most Fundable Companies List, which was announced during the virtual event yesterday.